Zivo Bioscience shareholders elect directors, ratify auditor, and approve executive compensation at annual meeting

Zivo Bioscience, Inc.

Elected John B. Payne and Alison A. Cornell as Class III directors with 1,681,190 and 1,681,001 votes for, respectively; broker non-votes 792,911.
Ratified BDO USA, P.C. as independent auditor for fiscal year 2025 with 2,438,089 votes for, 53,549 against, 15,420 abstain.
Advisory approval of named executive officer compensation: 1,665,583 for, 48,443 against, 121 abstain; broker non-votes 792,911.
Total shares present at meeting: 2,507,058 (66.11% of outstanding common stock).

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.